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Abstract 
 
Caffeine (1,3,7-trimethylxanthine), an ingredient of coffee, is used worldwide as a 
psychostimulant, antioxidant, and adjuvant analgesic. To gain insights into the action 
mechanism of caffeine, we report on its effects on the phase behaviour and microscopic 
dynamics of a dioctadecyldimethylammonium bromide (DODAB) lipid membrane, as 
studied quasielastic neutron scattering (QENS). Tracking the elastic scattering intensity as a 
function of temperature showed that caffeine does not alter the phase behaviour of the 
DODAB membrane and that transition temperatures remain almost unaltered. However, 
QENS measurements revealed caffeine significantly modulates the microscopic dynamics of 
the lipids in the system, and that the effects depend on the structural arrangement of the lipids 
in the membrane. In the coagel phase, caffeine acts as a plasticizing agent which enhances the 
membrane dynamics. However, in the fluid phase the opposite effect is observed; caffeine 
behaves like a stiffening agent, restricting the lipid dynamics. Further analysis of the QENS 
data indicates that in the fluid phase, caffeine restricts both lateral and internal motions of the 
lipids in the membrane. The present study illustrates how caffeine regulates the fluidity of the 
membrane by modulating the dynamics of constituent lipids depending on the physical state 
of the bilayer.  
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1. Introduction 
Caffeine (1,3,7-trimethylxanthine) is the world's most widely consumed legal psychoactive 
substance, used to avoid fatigue or to promote attentiveness [1].  It is a small amphiphilic 
molecule (Fig. 1) that has been widely investigated due to its potential antioxidant activity, 
exhibiting protective qualities against various human health disorders related to oxidative 
stress [2]. For example, the antioxidant properties of caffeine have shown protective effects 
against the development of Alzheimer's disease [3-4]. Caffeine is also used as an additive to 
enhance pain relief from non steroid anti-inflammatory drugs (NSAIDs), however the exact 
action mechanism of caffeine is still under debate [1,2,5]. Various mechanisms for caffeine’s 
action, such as mobilization of intracellular calcium, by inhibiting the binding of adenosine 
and benzodiazepine ligands to neuronal membrane-bound receptors, have been discussed in 
the literature [1,5].  Caffeine is also found to interact with lipid membranes [5-7]. However, 
limited information is available on the molecular mechanism of the interaction of caffeine 
with membrane, which plays a vital role in understanding its actions, accumulation, and 
metabolism. Furthermore, an understanding of this mechanism will also help in unraveling its 
impact on the distribution of drugs in the membrane. Recently, a study on unsaturated 
zwitterionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes with and 
without caffeine was carried out using diffraction and molecular dynamic (MD) simulation 
techniques [5]. It was found that caffeine penetrates into the POPC membranes and mainly 
locates at the head group–tail group interface of the bilayers. It significantly affects the 
membrane hydration by attracting water molecules from the membrane itself to form water 
pockets around itself [5]. The incorporation of caffeine leads to an increase of the membrane 
thickness, and an overall decrease of the gauche defects in the lipid tails indicating a decrease 
in the membrane fluidity [5]. In another study using anionic 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoglycerol (POPG) and zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) bilayers [6-7], it was shown that caffeine partitions in the lipid membrane and 
accumulates mainly just below the head group region. Furthermore, the effects of caffeine on 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/ dipalmitoyl phosphatidic acid (DPPA) 
membranes were also studied [8] in the presence and absence of tetracaine, a local anesthetic 
compound. The study showed that the incorporation of caffeine reduces the fluidization 
effects of tetracaine. Notwithstanding, the effects of caffeine on the microscopic dynamics on 
the lipids in the membrane remain unexplored in detail. Membrane dynamics play a key role 
in various physiological processes including cell signalling, energy transduction pathways, 
membrane trafficking, cell division, and bilayer permeability, and therefore, a detailed 
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knowledge of membrane dynamics is necessary for a deep understanding to the action 
mechanism of caffeine. 
 The dynamical behaviour of lipids in a membrane is rich encompassing a wide variety 
of individual molecular motions, like lateral lipid diffusion, lipid flip-flopping, rotational and 
vibrational motions, as well as collective motions that lead to bending motions and thickness 
fluctuation of the membrane [9-13]. Such a complex dynamical landscape occurs over several 
decades in time, ranging from molecular vibrations that occur in the femtosecond scale, to 
flip-flop of lipids that take place within a few hours. Equally individual molecular motions 
take place over very short length scales (a few Angstroms), collective motions leading to full 
membrane mobility span over lengthscales of up to a few microns. A multitude of techniques 
has been used to probe the dynamics of these systems in such broad temporal and spatial 
regimes, including nuclear magnetic resonance (NMR) [14], electron paramagnetic resonance 
(EPR) [15], fluorescence correlation spectroscopy (FCS) [16,17], dynamic light scattering 
(DLS) [18-19], and quasielastic neutron scattering (QENS) [20-26]. While most of the 
techniques offer insight into the relaxation timescales of the system, scattering techniques 
(e.g. QENS and DLS) have the advantage to provide both spatial and temporal information of 
the relaxation processes in the system. Owing to the wavelength and energy of thermal 
neutrons, QENS is particularly suited for studying molecular motions in lipid membranes on 
length scales ranging from Angstroms to nanometers, and on timescales between a few 
picoseconds and nanoseconds [20-26]. A number of studies have been carried out on self-
assembled surfactant and lipid aggregates using QENS, to unravel the dynamics of the 
constituent molecules in the system [20-30].  
 
Fig.1 Chemical structures of the DODAB lipid and caffeine 
 
Dioctadecyldimethylammonium bromide (DODAB) is a double chained cationic lipid 
(Fig. 1) which forms a lamellar structure in aqueous solution analogous to biological 
membranes and has been widely investigated due to their membrane mimetic properties [31-
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36]. Various recent studies have shown the usefulness of DODAB membranes for a number 
of biomedical applications such as antimicrobials [37-38], drug/vaccine delivery [39-41], and 
gene/DNA transfection [42]. Besides biomedical applications, DODAB lipids are of 
fundamental interest due to their rich phase behaviour which depends on temperature, lipid 
concentration, preparation method and membrane composition [43-45].  We have recently 
used QENS to investigate the phase behaviour and microscopic dynamics of DODAB lipid 
membranes [20]. 
Here, we report the effects of caffeine on the dynamical and phase behavior of a 
DODAB lipid membrane as studied using QENS. Scanning the temperature dependence of 
the elastic incoherent scattering signal, through the Elastic Fixed Window Scan (EFWS) 
method, as well as performing QENS experiments on DODAB lipid membranes with and 
without caffeine, have revealed various interesting results which indicate a complex interplay 
between charge, molecular architecture and location of additive within the membrane.  
 
2. Materials and Methods 
2.1 Materials and Sample Preparations 
Dioctadecyldimethylammonium bromide [DODAB, (C18H37)2N(CH3)2 Br] powder (>98%) 
was purchased from Tokyo chemical industries Co. ltd. Caffeine and  D2O (99.9%) were 
procured from Sigma Aldrich.  70 mM DODAB vesicles with and without 25 mol % caffeine 
were prepared by mixing the appropriate amounts of DODAB powder and caffeine in D2O as 
described before [20,36]. The mixtures were kept under magnetic stirring for about an hour at 
~ 340 K until a clear solution was obtained.  
 
2.2 Neutron Scattering Experiments 
Two kinds of measurements, namely elastic fixed window scan (EFWS), and quasielastic 
neutron scattering (QENS), were carried out on DODAB membranes with and without 
caffeine using the IRIS time-of-flight backscattering spectrometer [46] at the ISIS Pulsed 
Neutron and Muon Source (Rutherford Appleton Laboratory, UK). The IRIS spectrometer 
was used in energy offset mode with pyrolytic graphite (002) analyser. This offers an energy 
resolution of ~ 18 μeV, an energy transfer range of -0.3 to 1.0 meV and a Q-range of 0.5 to 
1.8 Å
-1
. EFWS experiments were carried out in the temperature range 285 K – 345 K in both 
heating and cooling cycles. QENS measurements were carried out at 310 K(during heating 
cycle) and 330K (during cooling cycle), to ensure DODAB lipids were in the coagel and fluid 
phase, respectively. The temperatures at which QENS data were recorded were chosen based 
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on the phase transitions observed in EFWS. To estimate the solvent contribution, QENS 
experiments were also carried out on pure D2O at the same temperatures of 310K and 330K. 
Standard aluminium annular sample holders with an internal spacing of 0.5 mm were used for 
the neutron scattering measurements, to ensure no more than 10% scattering and minimize 
multiple scattering effects. A QENS measurement was also carried out on standard vanadium 
to obtain the instrument resolution. MANTID software [47] was used to perform standard 
data reduction. 
 
3. QENS Data Analysis 
 QENS measurements provide insights into the correlation of dynamics in the system 
in the momentum-energy (Q, E) space. The incoherent scattering component is directly 
related to self-correlation part and therefore is useful in studying the diffusive motions in the 
system. The neutron scattering signal from a hydrogenous sample is dominated by the 
incoherent part due to the tremendously large incoherent scattering cross section of the 
hydrogen atoms (in comparison to any other atoms). This can be exploited to study the 
diffusion of lipids in the membrane systems. In aqueous solution, to minimize the scattering 
contribution from the solvent, D2O is used instead of H2O. Nonetheless, in order to obtain the 
scattering signal solely from the membrane in the solution the contribution of the solvent is 
subtracted using the following equation, 
 
                      ),(),(),( EQIEQIEQI solventsolutionmem                                (1) 
where,
 
ɸ is the fraction of solvent in the system. The subtracted intensity of the lipid 
membranes is used in the analysis of QENS data.  
As already mentioned, lipid membranes exhibit a complex hierarchy of dynamics 
spanning a wide range of time and length scales. QENS probes dynamics in a temporal 
regime from nanoseconds to sub picoseconds and at length scales ranging from Angstroms to 
nanometers. Two distinct motions of the lipids, lateral (~ns) and internal (~ps) motions, fall 
within these scales and can be observed using QENS [10,20-23]. The experimental data is 
fitted with the convolution of a model scattering law, Smem(Q, E) and the resolution function 
of the instrument. Smem(Q, E) is constructed by considering these two dynamically distinct 
degrees of freedom (lateral and internal) associated with the lipids in the membrane. 
Assuming these two motions are decoupled, the effective scattering law can be written as a 
convolution of their individual components, 
              
     int, , ,mem latS Q E S Q E S Q E                                             (2) 
6 
 
where, Slat(Q, E) and Sint(Q, E) correspond to the scattering laws associated to the lateral and 
internal motion of the lipids, respectively. Lateral motion pertains to the movement of the 
whole lipid molecule along the leaflet of the lipid membrane. A variety of models have been 
suggested for lateral motion of lipids, some of which include, ballistic flow like motion [23], 
subdiffusion [48], localised diffusion [49], and Fickian diffusion [26]. We have assumed 
simple Fickian diffusion, based on the recent study [26] which has shown that this is the case 
for the time and length scales accessible by QENS, and valid at least, for distances greater 
than a lipid molecule diameter.  With the assumption of this model, the explicit scattering law 
for lateral motion is given as 
 
  22/
1
,),(
lat
lat
latlatlat
E
ELEQS




    (3) 
where, Γlat is the half-width at half maximum (HWHM) of the Lorentzian corresponding to 
the lateral motion of lipid. The lateral diffusivity of lipids is obtained by fitting the HWHM 
with Γlat = DlatQ
2
. Meanwhile, the general scattering law associated to internal motion of 
lipids can be written as [10,50],
 
                           ELQAEQAEQS ,1, intintint                                (4) 
where, A(Q) is the elastic incoherent structure factor (EISF) and Lint(Γint, E) is the Lorentzian 
associated with internal motion. The EISF gives the elastic contribution to the QENS spectra, 
which arises due to the localised nature of the internal motion of the lipid. Different and more 
detailed models are presented in the next section, considering the structures and arrangements 
of lipid molecule in the different phases of the membrane.  
The resultant scattering law for the lipid membrane incorporating eqs. (3) and (4) into 
eq. (2),  
   
         int, , 1 ( , )mem lat lat tot latS Q E A Q L E A Q L E                          (5) 
 
3.1 Model for Internal Motions 
A DODAB molecule consists of two methyl units in the head group and two octadecyl alkyl 
chains (C18H37) as the tails, as shown in Fig.1. Thus the internal motions of each lipid 
molecule can be thought of consisting of the motion of methyl units in the head group plus 
the dynamics of the alkyl tails, separately. Hence, the resulting scattering law for internal 
motion can be written as a combination of these two components, one for the head group and 
one for the tails. In this case one can write, 
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     int , , ,h head t tailS Q E P S Q E PS Q E     (6) 
where Ph and Pt are the fractions of hydrogen atoms in head group and alkyl tails, 
respectively. For the DODAB molecule ((C18H37)2N
+
(CH3)2Br
-
), Ph and Pt are equal to 6/80 
and 74/80,  respectively. Here Shead(Q,E) and Stail(Q,E) are the scattering functions 
corresponding to the headgroup and alkyl tails, respectively. Methyl group dynamics are best 
described by a 3-fold jump diffusion model and can be written as [50],   
                
       0 0 2 2
31 1 2
, 1 2 ( ) 1 ( )
3 3 9
MG
head
MG
S Q E j Qa E j Qa
E


 
 
    
 
             (7)            
Here, a is the H-H distance (1.8 Å) in the methyl group and τMG is the mean residence time of 
a hydrogen atom in a MG in head. 
In coagel phase, lipid molecules are well ordered, and alkyl chains are in the trans 
conformation. In this phase, the alkyl tails could perform uniaxial rotational diffusion along 
their axis. In the corresponding theoretical model, hydrogen atoms in the alkyl chain undergo 
reorientations on a circle with a radius of gyration r. It has been shown that the scattering law 
for jump rotations among Ns equivalent sites with large Ns (> 6) and Qr  , can be used for 
uniaxial rotational diffusion [51]. Hence, the scattering law for alkyl tails in coagel phase can 
be given as [51], 
1
0 2 2
1
1
( , ) ( ) ( ) ( )
1
sN
uni n
tail n
n n
S Q E B Qr E B Qr
E


 


 


  (8)
 
with  
0
1
1 2
( ) 2 sin cos
sN
n
is s s
i ni
B Qr j Qr
N N N
 

 
  
 

    (9)
 
and 𝜏𝑛
−1 = 2𝜏−1𝑠𝑖𝑛2(
𝑛𝜋
𝑁𝑠
). Here j0 is spherical Bessel function of the zeroth order and τ is the 
average time spent on a site between two successive jumps. In this case, the rotational 
diffusion constant Dr can be written as: 
22 sinr
s
D
N


 
  
       (10) 
Further, it is possible that at a given temperature, all hydrogen atoms in the alkyl tails might 
not be mobile within the observation time scale of the spectrometer, and thus only a fraction 
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px takes part in the dynamics. Combining all these components together, we write the 
scattering law for internal motions in the coagel phase as, 
int
1
0 2 2 2 2
1
2 31
( , ) ( ) ( ) [1 ( )] ( )
3 9 1
sN
coagel h MG n
coagel x t n
nMG n
P
S Q E A Q E j Qa p P B Qr
E E
 

  


 
    
  

(11)
 
where Acoagel (Q) is the EISF for the coagel phase and can be written as, 
0 0
1
( ) [1 2 ( )] (1 ) 2 sin
3
sN
h x
coagel t x t
is s
P p i
A Q j Qa P p P j Qr
N N


  
       
  

  (12)
 
 In the fluid phase, the DODAB membrane is noticeably more disordered with 
significant number of gauche defects in the alkyl tails and a large area per lipid molecule. 
This allows lipids to perform a variety of localised motions such as conformational 
transitions, bending and stretching motions, chain reorientations, etc. To model this and 
incorporate the large flexibility of alkyl chains in the fluid phase, a localised translational 
diffusion (LTD) model with varying radii and diffusivities along the chain, is chosen. The 
scattering law associated to the LTD model is given by [52]:  
   
2
0
0 2
2 2
1 , 0,0
( ) /1 1
( , ) ( ) ( ) (2 1) ( )
( ) /
c
n
N l
LTD l n i i
tail i i
l
i l nc n i i
x D R
S Q E A QR E l A QR
N x D R E

 
 
   
     
 
(13)
 
where, Ri and Di are the radius and diffusivity of i
th
 CH2 units along the chain beginning from 
the headgroup and NC is the number of CH2 units in alkyl chain in the lipid – equal to 18 for 
the DODAB molecule. A0
0
 and An
l
 are the elastic and quasielastic structure factors 
respectively associated to the LTD model [52]. Combining the above equation with the 
scattering law for the headgroup (eq. 7), we obtain the following expression for Sint(Q, E) in 
the fluid phase,  
 
 
 
 
   
   
 
 
  
2
1
0
1
int 2
2
0 22 2 2
2 21 , 0,0
374
2 1 2 ( )
1
,
80
31 74
4 1 ( ) 2 1
9
C
C
N
i
iC i
fluid
lN
n i ilMG
n i
li l nMG C
n i i
j QR
j Qa E
N QR
S Q E
x D R
j Qa l A QR
E N
x D R E


 

 
         
    
 
   
  
    
  
   

 
 (14)
 
 
The EISF for the DODAB lipid in the fluid phase can be written as 
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 
 
2
1
0
1
31 74
2 1 2 ( )
80
CN
i
iC i
j QR
EISF j Qa
N QR
  
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   
 ,
   (15)
 
but owing to the increasing flexibility of the chain as one goes from the head down along the 
length of the tail, the distribution of radii and diffusivities of CH2 units are considered to 
increase as it tends towards the tail. A variety of distributions have been used for lipid bilayer 
systems, such as linear [22], half-Lorentzian [45], etc. In this work, we shall be considering 
the simplest linear model given by, 
    minminmaxminminmax
1
1
1
1
DDD
N
i
DRRR
N
i
R
C
i
C
i 





   (16) 
where Rmin and Dmin are the minimum radius and diffusivity which are associated with the 
CH2 units nearest the headgroup, and Rmax and Dmax are the maximum radius and diffusivity 
associated with the CH2 units at the end of alkyl chain.  
 
4. Results and Discussion 
4.1 Phase Behaviour 
In an Elastic Fixed Window Scan (EFWS), the sample temperature is varied in small 
steps and the elastic intensity (within the energy resolution of the spectrometer) is recorded at 
each temperature. Increasing the temperature enhances the dynamics in the system, which in 
turns leads to a loss in the elastic intensity. Any abrupt change in the elastic intensity is the 
signature of the phase transition associated with the microscopic dynamics of the system. 
Assuming incoherent scattering, this technique is very useful to investigate the phase 
behaviour in lipid membrane systems [20,25]. EFWS measurements were carried out on 
DODAB membranes with and without caffeine, while heating as well as while cooling, to 
investigate the effects of caffeine on the phase behaviour. The measured EFWS data is 
plotted in Fig. 2. 
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Fig. 2 Q-averaged neutron elastic intensity scans for DODAB vesicles in the absence and 
presence of caffeine in heating and cooling cycles.  
 
Upon heating, DODAB membranes transition from a coagel to a fluid phase at 327K. 
However, in the cooling cycle, the fluid phase does not go directly into a coagel phase, but 
passes through an intermediate gel phase. Moreover, a large hysteresis is observed between 
the heating and cooling cycles. The existence of an intermediate gel phase in the cooling 
cycle can be rationalized based on a non-simultaneous change in the dynamics of the polar 
head groups and the tail groups. The alkyl chains interact mostly via weak van der Waals 
forces, while a strong electrostatic repulsive interaction exists between the charged head 
groups. As the temperature is lowered, this causes the hydrophobic alkyl chain tails to order 
much earlier than the smaller charged head groups, leading to the formation of the gel phase 
– where the headgroups are still significantly disordered, while the tails are in the ordered 
state. This behaviour is in  strong contrast to that observed in conventional phospholipids 
such as DMPC, primarily due to differences in the size and polarity of the headgroups 
[10,28].  
The results from the EFWS measurements show that the addition of caffeine does not 
significantly affect the phase behavior of the DODAB membrane, with the transition 
temperatures remaining almost unaltered.  This is rather different to the effects of non-steroid 
anti-inflammatory drugs (NSAIDs) on a similar DODAB membrane to that used here (same 
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concentration). Results from a recent study [36], showed that upon heating, the temperature 
corresponding to the coagel to fluid phase transition shifts towards a lower temperature, and 
upon cooling, the NSAIDs inhibit the formation of the intermediate gel phase. The fact that 
caffeine does not induce similar or any changes to the phase behavior could be due to its 
exceptionally high pKa (=14) compared to NSAIDs like aspirin, indomethacin whose pKa 
values are in the range 3 to 5 [5,53]. This indicates that at neutral pH, these NSAID 
molecules are in anionic form in the solution with DODAB, unlike caffeine which mostly in 
its cationic state. The anionic NSAIDs screen the strong electrostatic repulsion between the 
positively charged headgroups and effectively cause synchronous ordering between the polar 
head and hydrophobic tails during cooling, thereby suppressing the formation of the gel 
phase. On the other hand and due to the high pKa, the caffeine molecule possesses a positive 
charge and strong affinity to water. Therefore, although it remains near the polar region of the 
membrane, it does not screen the interactions between headgroups and hence doesn’t 
significantly alter the phase behavior of DODAB membrane. Similar behavior has been 
observed in phospholipid membranes [8]. While the incorporation of NSAIDs lead to a 
marked effect on their phase behavior, causing a decrease in the main transition temperature, 
caffeine does not [19,25].  
 
4.2 Microscopic Dynamics of Lipids  
Having established the phase behavior of the lipids with and without caffeine and that the 
dynamics in each phase are within the instrument’s observation range, we now characterize 
the molecular motions in detail in each of the. D2O subtracted QENS spectra for DODAB 
membrane with and without caffeine at 310K (coagel phase) and 330K (fluid phase) at a 
representative value of Q of 1.2 Å
-1
 are shown in Figs. 3a and b, respectively. The instrument 
resolution as measured with a standard vanadium sample, is also shown in Fig. 3a, and to 
compare the results, the spectra are normalized by their peak amplitude. Significant 
quasielastic broadening is present for DODAB membrane with and without caffeine at both 
temperatures measured, suggesting the presence of stochastic motions of the lipids in the 
system. It is evident from the data that the effect of caffeine on the dynamics of the lipids in 
the membrane is strongly dependent on the physical state of the membrane. In the coagel 
phase, the addition of caffeine shows a slight increase in the quasielastic broadening, 
suggesting an enhancement of the lipid dynamics. On the other hand, its effect is contrary in 
the fluid phase, as addition of caffeine leads to a decrease in the quasielastic broadening 
which indicates a stiffening of the membrane.  
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Fig. 3 Typical observed QENS spectra at a representative Q =1.2 Å
-1
 for DODAB membrane 
in absence and presence of caffeine in (a) coagel (310K) and (b) fluid (330K) phases. The 
instrument resolution as measured from a vanadium standard is shown by the dashed line in 
the left panel. The contribution of the solvent (D2O) has been subtracted, and the resultant 
spectra are normalized to the peak amplitude for a quantitative comparison. 
 
4.2.1 Coagel Phase 
The QENS spectra is analysed by fitting to eq. (4) as shown for a representative Q = 
1.4 Å
-1
 in Figs. 4a and 4b, for the membrane without and with caffeine, respectively. The data 
fits well to the model indicating that only internal motion of the lipids is observable within 
the resolution of the IRIS spectrometer. This could be due to fact that in coagel phase, lipids 
are in a densely packed and ordered state, which results in extremely slow lateral motion that 
is not accessible by the spectrometer. The parameters obtained from the fits, the EISF, A(Q), 
and the HWHM, Γint (Q), are plotted as a function of Q in Figs. 5a and 5b respectively. It is 
directly evident from the EISF in Fig. 5a, that the addition of caffeine promotes disorder in 
the coagel phase of the membrane. The EISF is modeled considering a 3-fold rotation for the 
headgroup and a fractional uniaxial rotation of the tail, as described by eq. (12). The obtained 
parameters, the radius of gyration (r) and the mobile fraction (px) are listed in Table I. A 
notable rise in both the mobile fraction of hydrogen atoms and the radius of gyration is 
observed. The uniaxial rotational diffusion constant, Dr, and the mean residence of the H-
atom’s 3-fold reorientation, τMG, are obtained by fitting the HWHM of internal motion (Γint) 
calculated numerically from eq. (11). The fits shown by continuous and dashed lines for 
DODAB membrane with and without caffeine, respectively, in Fig. 5b, suggest that the 
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considered model is suitable for the system in coagel phase. The values are given in Table I 
and indicate a moderate increase in Dr and a decrease in τMG, supporting the idea of an 
increased disorder of the membrane in the coagel due to caffeine. The coagel phase of the 
DODAB membrane is the most ordered phase, with almost all the lipids in all-trans 
conformation. The introduction of caffeine in the membrane can perturb the ordering of lipids 
in this phase and therefore lead to the observed increase in local dynamics of the system. 
However, the extent of perturbation is significantly small when compared with the effects of 
NSAIDs such as aspirin or indomethacin [36]. This suggests that caffeine is weakest 
plasticizing agent among them for DODAB in the coagel phase. 
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Fig. 4 QENS spectra in coagel phase (310K) fitted with Eq. (4), at a representative Q = 1.4 Å
-
1
 for (a) DODAB and (b) DODAB+Caffeine membranes. Individual elastic (blue) and 
quasielastic (pink) components of the QENS fit are also shown.   
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Fig. 5 (a) EISF and (b) Γint for DODAB in absence and presence of caffeine in the coagel 
phase (310 K, heating cycles). The solid and dashed lines represent fits assuming fractional 
uniaxial rotational model as described in the text. 
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Table-I Parameters associated to internal motion of DODAB lipid in the coagel phase (310K 
in heating cycle) with and without caffeine. 
 
 
px(%) r (Å) 
τMG 
(ps) 
Dr (10
10
 s
-1
) 
DODAB  13±3 1.7±0.2 6.7±0.3 2.1±0.3 
DODAB+Caff 16±2 1.9±0.2 6.0±0.3 3.0±0.3 
 
 
4.2.2 Fluid Phase 
The DODAB membrane in the fluid phase exhibits a dynamically richer behaviour 
with both lateral and internal motion quite discernible from QENS spectra. The introduction 
of caffeine in the membrane shows a significant decrease in the lipid dynamics, suggesting 
that caffeine is a stiffening agent which retards the lipid dynamics in the system. The QENS 
spectra of the DODAB membrane with and without caffeine are fitted using eq. (5) 
accounting for both the lateral and internal motion in the system. The spectra, fits and the 
individual components (lateral and lateral+internal) are shown at a representative Q-value in 
Figs. 6a and b, for DODAB without and with caffeine, respectively. It is clear from the fits 
that the timescale of lateral and internal motions of the lipids are well separated.  
The HWHM of the lateral motion (Γlat) of the lipids for both the cases is plotted as a 
function of Q
2
 in Fig. 7, in addition to the linear fits based on Fickian diffusion model (Γlat = 
DlatQ
2
). The obtained lateral diffusion constants, Dlat, for DODAB are listed in Table 2, and 
evidence the strong effect of caffeine, by a factor of 2. This significant reduction of lateral 
mobility might be due to local dehydration of lipid membrane interface in the presence of 
caffeine which strongly hydrates itself at the cost of the membrane [5]. The effect of caffeine 
on the lateral motion of DODAB lipids in the fluid phase is much more significant than that 
observed from the common NSAID indomethacin [36]. This indicates that caffeine is the 
stronger stiffening agent for DODAB in the fluid phase.  
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Fig. 6 QENS spectra in the fluid phase (330K) at a representative Q = 1.4 Å
-1
 for (a) DODAB 
and (b) DODAB+Caffeine membranes, fitted with Eq. (5). Individual components of the 
QENS fit corresponding to lateral (blue and narrower) and lateral+internal (pink and broader) 
are also shown.   
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Fig. 7  Variation of half width at half maximum (HWHM) of the Lorentzian corresponding to 
lateral motion of lipid, Γlat with Q
2
 for DODAB membrane with and without caffeine at 
330K. The solid and dashed lines represent the Fickian diffusion description as discussed in 
text. 
The fitting parameters A(Q) and Γint, used to characterise the internal motion of the 
lipids in the fluid phase, are obtained from fitting the QENS spectra and are plotted in Figs. 
8a and 8b, for DODAB with and without caffeine, respectively. In lieu of increased disorder 
in the fluid phase, the internal dynamics of the lipids are approximated using a localised 
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translational diffusion (LTD) model with a linearly increasing radii and diffusivities along the 
length alkyl chain, as explained in section 3. The fits are shown as lines in Fig. 8. The values 
of Rmin and Dmin are found to very small essentially indicating that the CH2 units near the 
headgroup show negligible movement. The values of Rmax, Dmax and τMG are given in Table 
II. Clearly the addition of caffeine leads to a decrease of the diffusivity and an increase in the 
residence time τMG, both indicating a stiffening effect on the internal motion of the lipid in the 
fluid phase. Again, in comparison with indomethacin, caffeine has much stronger effect on 
internal dynamics of lipids in the fluid phase.  
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Fig. 8 Variation with Q of the (a) elastic incoherent structure factor (EISF) and (b) half width 
at half maximum (HWHM) of the Lorentzian corresponding to the internal motion of lipid, 
Γint for the DODAB membrane in absence and presence of caffeine at 330K. The solid and 
dashed lines are the fits according to localised translational diffusion as described in the text. 
 
 
Table-II Parameters associated to lateral and internal motions of DODAB lipid with 
and without caffeine in the fluid phase (330K).  
 Lateral motion Internal motion 
Dlat (10
-6
 cm
2
/s) Rmax (Å) Dmax (10
-6
 cm
2
/s) τMG (ps) 
DODAB 2.2 ± 0.1 4.2 ± 0.2 17.7±0.4 4.5±0.2 
DODAB+Caff 1.2 ± 0.1 4.9 ± 0.3 13.2±0.3 5.7±0.4 
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The detailed analysis of QENS spectra of DODAB membrane in both coagel and fluid 
phase reveals that the effect of caffeine’s presence in the membrane is strongly phase 
dependent. In the coagel, caffeine causes a slight disorder in the membrane, behaving like 
weak plasticizer. However, in the fluid phase, the effect of caffeine is strong and behaves as a 
stiffening agent inhibiting both lateral and internal motion. 
 
5. Conclusions 
Incoherent elastic intensity scans and quasielastic neutron scattering experiments have 
revealed interesting effects of caffeine on the microscopic dynamics and phase behaviour of 
DODAB lipid membranes. The results have been compared to common NSAID’s. Elastic 
fixed window scan measurements showed that the incorporation of caffeine neither shifts the 
coagel to fluid phase transition in the heating cycle nor inhibits the intermediate gel phase in 
the cooling cycle. This is in stark contrast to strong effects shown by NSAID’s [36]. Further, 
a detailed analysis of the quasielastic neutron scattering data on DODAB lipid membranes in 
the absence and presence of caffeine, in both coagel and fluid phases, reveals that the 
addition of caffeine significantly modulates the dynamics of lipid membrane, however with 
different effects in both phases. In the coagel phase, lipid dynamics are slightly enhanced, 
whereas in the fluid phase, caffeine restricts lipid mobility quite significantly. Both lateral 
and internal motions of the lipid are reduced due to the incorporation of caffeine.  The results 
are explained in terms of the charge, molecular architecture, hydration and location of 
additive within the membrane. The present study sheds some more insight into how caffeine 
interacts with the membrane and reveals a profound link between the nano-scale structure and 
the microscopic dynamics of lipids in the membrane. This might be useful to understand the 
action of other additives of similar chemical and physical properties on membranes. 
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